期刊文献+

晚期肺腺癌患者外周血T细胞淋巴亚群的检测及危险因素评估 被引量:4

Detection of T Lymphocyte Subsets in the Peripheral Blood of Patients with Advanced Lung Adenocarcinoma
下载PDF
导出
摘要 目的探讨晚期肺腺癌患者CD4+CD25+Treg细胞和其他T细胞亚群的变化及其临床意义。方法采用流式细胞术分析64例晚期肺腺癌患者外周血CD4+CD25+Treg细胞及其他T细胞亚群水平,并与33例健康对照者比较。结果晚期肺腺癌患者CD3+和CD3+CD4+比例分别为(66.5±11.0)%和(37.7±10.6)%,明显低于健康对照组的(72.0±6.0)%(t=-3.2,P=0.020)和(42.0±6.4)%(t=-2.4,P=0.015);CD4+CD25+的比例为(10.5±4.0)%,明显高于健康对照组的(8.4±3.5)%(t=-2.2,P=0.013);CD4+/CD8+为1.4±0.8,明显低于健康对照组的1.8±0.7(t=-2.2,P=0.029)。两组间CD3+CD8+、CD8+CD28-及CD8+CD28+的比例差异无统计学意义(P均>0.05)。肺癌患者T细胞亚群功能的损害与吸烟与否、肿瘤分化程度及肿瘤病灶大小无明显联系,与外周血癌胚抗原之间存在着一定的联系。结论晚期肺腺癌患者存在明显的细胞免疫功能障碍,Treg细胞在肺癌患者中比率明显升高,CD4+/CD8+明显降低,提示肺癌患者处于免疫抑制状态。吸烟与否、分化程度及肿瘤病灶大小与免疫功能紊乱的联系尚需进一步探讨。 Objective To evaluate the CD4 + CD25 + regulatory T cells (Treg) and other lympho- cyte subsets in the peripheral blood of patients with advanced lung adenoearcinoma. Methods Peripheral blood samples were obtained from 64 patients with advanced lung adenocareinoma ( case group) and analyzed by flow cytometry. The ratios of CD4 + CD25 + Treg T cells and other T lymphocyte subsets in peripheral blood were compared with those from 33 healthy controls ( control group). Results The percentages of CD3 + and CD3 + CD4 + were (66.5±11.0)% and (37.7±10.6)% respectively in the peripheral blood of the case group, which were significantly lower than those [ (72.0±6.0) % and (42.0±6.4) % ] in the control group ( t = - 3.2, - 2.4 ; P = 0. 020, 0. 015, respectively). The ratio of CD4 + CD25 + Treg cells in case group (10.5 +4.0)% was significantly higher than that [ (8.4±3.5)% ] in the control group (t = -2.2, P =0.013). CD4 +/CD8 + value of case group ( 1.4±0. 8 ) was significantly lower than that ( 1.8 _+ 0.7) in control group (t = - 2.2, P = 0. 029). CD3 + CD8 + , CD8 + CD28-, and CD8 + CD28 + showed no signifi- cant differences ( all P 〉 0.05 ) . Smoking, differentiation grade, and size of the tumor showed no association with the function damage of T lymphocyte subsets, while the carcino-embryonic antigen level did. Conclusions In patients with advanced lung adenocarcinoma, Treg increases and CD4 +/CD8 + decreases, suggesting re- markably suppressed immune functions. However, more research is warranted to validate the association of T cells subset dysfunction with smoking, differentiation grade, and size of tumor.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2012年第3期234-238,共5页 Acta Academiae Medicinae Sinicae
基金 军队十一五医药科研课题项目基金(06G106)~~
关键词 晚期肺腺癌 CD4+CD25+调节性T细胞 T细胞亚群 流式细胞术 advanced stage adenocarcinoma cell lung cancer CIM + CD25 + regulatory T cells T lymphocyte cells subset flowcytometry
  • 相关文献

参考文献16

  • 1Berendt M J,North RJ. T-cell-mediated suppression of antitumor immunity.An explanation forprogressive growth of an immunogenic tumor[J].Journal of Experimental Medicine,1980,(01):69-80. 被引量:1
  • 2Bursuker I,North RJ. Generation and decay of the immune response to a progressive fibrosarcoma.Ⅱ.Failure to demonstrate postexcision immunity after the onset of T cell-mediat-edsuppression of immunity[J].Journal of Experimental Medicine,1984,(05):1312-1321. 被引量:1
  • 3North RJ,Bursuker I. Generation and decay of the immune response to a progressive fibrosarcoma.I.Ly-1 + 2-suppressor T cells down-regulate the generation of Ly-1-2 + effector Tcells[J].Journal of Experimental Medicine,1984,(05):1295-1311.doi:10.1084/jem.159.5.1295. 被引量:1
  • 4Hernberg M. Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy[J].Medical Oncology,1999,(03):145-153.doi:10.1007/BF02906126. 被引量:1
  • 5Garcia-Suarez J,Krsnik I,Reyes E. Elderly haematological patients with chemotherapy-induced febrile neutropeniahave similar rates of infection and outcome to younger adults:a prospectivestudy of risk-adapted therapy[J].British Journal of Haematology,2003,(02):209-216.doi:10.1046/j.1365-2141.2003.04045.x. 被引量:1
  • 6Hong C,Lee H,Oh M. CD4 + T cells in the absence of the CD8 + cytotoxic T cells are critical andsufficient for NKT cell-dependent tumor rejection[J].Journal of Immunology,2006,(10):6747-6757. 被引量:1
  • 7Batliwalla FM,Rufer N,Lansdorp PM. Oligoclonal expansions in the CD8 (+) CD28 (-) T cells largely explain the shortertelomeres detected in this subset:analysis by flow FISH[J].Human Immunology,2000,(10):951-958.doi:10.1016/S0198-8859(00)00157-9. 被引量:1
  • 8Filaci G,Fenoglio D,Fravega M. CD8 + CD28-T regulatory lymphocytes inhibiting T cell proliferative and cytotoxicfunctions infiltrate human cancers[J].Journal of Immunology,2007,(07):4323-4334. 被引量:1
  • 9Meloni F,Morosini M,Solari N. Foxp3 expressing CD4 + CD25 + and CD8 + CD28-T regulatory cells in the peripheralblood of patients with lung cancer and pleural mesothelioma[J].Human Immunology,2006,(1-2):1-12. 被引量:1
  • 10Karagoz B,Bilgi O,Gumus M. CD8 + CD28-cells and CD4 + CD25 + regulatory T cells in the peripheral blood of advanced stage lung cancer patients[J].Medical Oncology,2010,(01):29-33. 被引量:1

同被引文献30

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部